SHPMF (Shanghai Pharmaceuticals Holding Co) ROCE %: 11.37% (As of Mar. 2026)


SHPMF Shanghai Pharmaceuticals Holding Co Ltd SHPMF
77 GF Score
Price $1.46
GF Value $1.86
! 4 Warning Signs
View Full Analysis

What is Shanghai Pharmaceuticals Holding Co ROCE %?

Shanghai Pharmaceuticals Holding Co SHPMF -4.58% 77 ROCE % is 11.37% as of Mar. 2026. GuruFocus rates SHPMF with a GF Score™ of 77/100 and a GF Value™ of $1.86. The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Shanghai Pharmaceuticals Holding Co's annualized ROCE % for the quarter that ended in Mar. 2026 was 11.37%.

Shanghai Pharmaceuticals Holding Co  (OTCPK:SHPMF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Shanghai Pharmaceuticals Holding Co ROCE % Related Terms

Shanghai Pharmaceuticals Holding Co ROCE % Historical Data

* Premium members only.

The historical data trend for Shanghai Pharmaceuticals Holding Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Pharmaceuticals Holding Co ROCE % Chart

Shanghai Pharmaceuticals Holding Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.74 12.66 9.98 10.59 12.11

Shanghai Pharmaceuticals Holding Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.94 21.29 7.68 7.92 11.37
SHPMF
77GF Score
Shanghai Pharmaceuticals Holding Co Ltd SHPMF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Pharmaceuticals Holding Co ROCE % Calculation

Shanghai Pharmaceuticals Holding Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=1633.589/( ( (30382.989 - 17311.301) + (33102.676 - 19195.551) )/ 2 )
=1633.589/( (13071.688+13907.125)/ 2 )
=1633.589/13489.4065
=12.11 %

Shanghai Pharmaceuticals Holding Co's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=1605.804/( ( (33102.676 - 19195.551) + (34150.619 - 19806.537) )/ 2 )
=1605.804/( ( 13907.125 + 14344.082 )/ 2 )
=1605.804/14125.6035
=11.37 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 11.37% mean?
Shanghai Pharmaceuticals Holding Co (SHPMF) has a ROCE % of 11.37% as of Mar. 2026.
Is Shanghai Pharmaceuticals Holding Co's ROCE % too high?
Shanghai Pharmaceuticals Holding Co's current ROCE % is 11.37%. The Medical Distribution industry median ROCE % is 9.09. Shanghai Pharmaceuticals Holding Co's value of 11.37% is 25.1% above this industry median. Overall, Shanghai Pharmaceuticals Holding Co has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Shanghai Pharmaceuticals Holding Co's ROCE % compare to MCK and CAH?
Shanghai Pharmaceuticals Holding Co's ROCE % of 11.37% can be compared against companies in the Medical Distribution industry. The industry median ROCE % is 9.09. Shanghai Pharmaceuticals Holding Co's value of 11.37% is 25.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Distribution company?
The median ROCE % among Medical Distribution companies is 9.09, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Pharmaceuticals Holding Co's current ROCE % of 11.37% is 25.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median ROCE % is 9.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Pharmaceuticals Holding Co's current ROCE % is 11.37%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Pharmaceuticals Holding Co stock overvalued right now?
Shanghai Pharmaceuticals Holding Co (SHPMF) has a current ROCE % of 11.37%. The stock's GF Value™ is $1.86, compared to a current price of $1.46 — trading 21.5% below its estimated fair value. The current ROCE % is 11.37% and 25.1% above the Medical Distribution industry median of 9.09. Shanghai Pharmaceuticals Holding Co's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Shanghai Pharmaceuticals Holding Co (SHPMF), the current ROCE % is 11.37% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Pharmaceuticals Holding Co (SHPMF) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Pharmaceuticals Holding Co stock appears to be undervalued. The current stock price of $1.46 is trading 21.5% below its estimated GF Value™ of $1.86.

Key valuation signals for SHPMF:

  • ROCE %: 11.37%
  • GF Value™: $1.86 vs. price of $1.46 (21.5% below fair value)
  • GF Score™: 77/100 with 4 warning signs
  • Industry Position: 25.1% above the Medical Distribution median

No single metric tells the full story. See the SHPMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Pharmaceuticals Holding Co Business Description

Address No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020
Shanghai Pharmaceuticals Holding Co Ltd is engaged in the pharmaceutical drug development and distribution business. The Group's reportable segments are: Production, Distribution, Retail, and Other. The majority of its revenue comes from the Distribution segment, which is mainly engaged in distribution, warehousing, and other value-added pharmaceutical supply chain solutions and related services for pharmaceutical manufacturers and dispensers. The Retail segment operates a network of retail pharmacy stores, and the Production segment is mainly engaged in research and development, production, and sales of a broad range of pharmaceutical and healthcare products. Geographically, the Group mainly operates in the People's Republic of China (PRC).
77GF Score

Get the complete analysis for SHPMF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.46
Price
$1.86
GF Value